Internal Medicine, Nephrology · Sumter, SC
NPI
1912258567
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
115 N Sumter St Ste 315
Sumter, SC, 29150
Phone (803) 252-9907
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
3,570 services
Medicare patients, 2024
496
Average age 74
Drug cost, 2024
$640K
946 prescriptions
Company payments, 2025
$331
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed Z Alzubaidi was code 80069 (clinical chemistry), 298 times for 164 patients. In total Mohammed Z Alzubaidi billed 3,570 services in 39 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80069 Clinical Chemistry | Office | 298 | 164 | $8.49 | $2,529 |
| 85025 Blood Count | Office | 272 | 157 | $7.61 | $2,070 |
| 99214 Office E&M - Established | Office | 254 | 151 | $55.10 | $14K |
| 83970 Clinical Chemistry | Office | 236 | 147 | $40.45 | $9,546 |
| 36415 Venipuncture Blood Collection | Office | 227 | 134 | $8.65 | $1,964 |
| 99232 Hospital E&M - Subsequent | Facility | 225 | 126 | $59.29 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 224 | 122 | $11.41 | $2,555 |
| 84156 Clinical Chemistry | Office | 201 | 133 | $3.59 | $721 |
| 82570 Clinical Chemistry | Office | 201 | 134 | $5.06 | $1,017 |
| 90960 ESRD Related Services (not dialysis) | Office | 182 | 44 | $265.29 | $48K |
| 99233 Hospital E&M - Subsequent | Facility | 143 | 76 | $89.41 | $13K |
| 83540 Clinical Chemistry | Office | 139 | 93 | $6.34 | $881 |
| 83550 Clinical Chemistry | Office | 139 | 93 | $8.57 | $1,191 |
| 82728 Clinical Chemistry | Office | 139 | 94 | $13.36 | $1,857 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 118 | 43 | $40.18 | $4,741 |
By year: 2022 $139K for 2,896 services; 2023 $152K for 2,698 services; 2024 $148K for 3,570 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80069 Clinical Chemistry | 298 | 164 | $8.49 | $2,529 |
| 85025 Blood Count | 272 | 157 | $7.61 | $2,070 |
| 83970 Clinical Chemistry | 236 | 147 | $40.45 | $9,546 |
| 36415 Venipuncture Blood Collection | 227 | 134 | $8.65 | $1,964 |
| 84156 Clinical Chemistry | 201 | 133 | $3.59 | $721 |
| 82570 Clinical Chemistry | 201 | 134 | $5.06 | $1,017 |
| 83550 Clinical Chemistry | 139 | 93 | $8.57 | $1,191 |
| 82728 Clinical Chemistry | 139 | 94 | $13.36 | $1,857 |
| 83540 Clinical Chemistry | 139 | 93 | $6.34 | $881 |
| 81001 Clinical Chemistry | 71 | 62 | $3.11 | $221 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed Z Alzubaidi prescribed most often to Medicare patients was Velphoro (Sucroferric Oxyhydroxide), with 111 prescriptions and refills. In total Mohammed Z Alzubaidi wrote 946 Medicare prescriptions that cost $640K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Velphoro Sucroferric Oxyhydroxide | 111 | 119 | 33 | $252K |
| Nifedipine Er Nifedipine | 51 | 136 | 16 | $1,853 |
| Carvedilol Generic | 44 | 92 | 11 | $462 |
| Furosemide Generic | 38 | 95 | 17 | $298 |
| Procrit Epoetin Alfa | 37 | 37 | Under 11 | $33K |
| Torsemide Generic | 37 | 65 | 11 | $900 |
| Tamsulosin Hcl Generic | 35 | 79 | Under 11 | $709 |
| Amlodipine Besylate Generic | 34 | 87 | 12 | $260 |
| Hydralazine Hcl Generic | 31 | 43 | Under 11 | $569 |
| Losartan Potassium Generic | 28 | 82 | Under 11 | $422 |
| Sevelamer Carbonate Generic | 25 | 49 | 14 | $5,323 |
| Indapamide Generic | 24 | 60 | Under 11 | $397 |
| Auryxia Ferric Citrate | 23 | 35 | Under 11 | $59K |
| Telmisartan Generic | 23 | 35 | Under 11 | $1,302 |
| Midodrine Hcl Generic | 21 | 43 | Under 11 | $535 |
Brand drugs: 283 claims; generic drugs: 663 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed Z Alzubaidi $331 ($331 in general payments such as food, travel and fees) from 7 companies. The largest payer was NxStage Medical, Inc. with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.